ReposiTrak Inc. (NYSE:TRAK - Get Free Report) declared a quarterly dividend on Friday, June 20th, RTT News reports. Shareholders of record on Monday, June 30th will be given a dividend of 0.0182 per share on Thursday, August 14th. This represents a $0.07 dividend on an annualized basis and a dividend yield of 0.36%.
ReposiTrak has a dividend payout ratio of 18.9% meaning its dividend is sufficiently covered by earnings.
ReposiTrak Stock Performance
TRAK opened at $20.31 on Friday. The company has a debt-to-equity ratio of 0.01, a current ratio of 6.03 and a quick ratio of 6.03. ReposiTrak has a 52 week low of $14.23 and a 52 week high of $25.01. The company has a market capitalization of $371.27 million, a PE ratio of 59.74 and a beta of 0.54.
Insider Buying and Selling
In related news, CEO Randall K. Fields sold 2,500 shares of the company's stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $22.26, for a total value of $55,650.00. Following the sale, the chief executive officer now owns 197,000 shares in the company, valued at $4,385,220. This represents a 1.25% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders sold a total of 30,000 shares of company stock worth $639,585 in the last three months. 44.00% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
Separately, Wall Street Zen upgraded ReposiTrak from a "hold" rating to a "buy" rating in a report on Thursday, May 22nd.
Get Our Latest Stock Report on TRAK
About ReposiTrak
(
Get Free Report)
Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ReposiTrak, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.
While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.